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Perculaneous bottom aortic vaivulopiasty was used to prospec-
lieely (real 492 elderly, symptomatic, nonsurgical patients sut-
tering from severe aortic stenmis in 27 centers in North America
and Europe. At I year the overall survival rate was 64% and the
event-free survival rate (survival free of valve replacement or
repeat valvulaplasty) was 43% . Clinical, catheteritard" and
procedural variables were
assessed
to define prognostic variables .
Hnharlate analysis revealed that patients who survived had a
lesser frequency of previous myocardial infarction (2% versus
6%, p < 0.005), Iowa incidence of severe sentrirulardy9function
(22% versus 48%, p < 0.0011 and lower Incidence of symptoms of
heartfallure (60% versus 75h, p < 0.02) . History of angina 156 1,
versm 45%, p = NS) and symWpe (23% rerun 16%, p = N91
were simelar for both groups . Values obtained at cardiac rmhei
terifsUon that differed in aurrivcrs and nonsunivas included
lower pulmonary artery systolic pressure (43 i 1 versus 54 s
2 mm Hg, p 0.001), lower mean pulmonary artery pressure
(20 ± 1 .0 versus 36 f 1.0 mm Hg, p < 0 .0011 and larger initial
value area (0.52 t 0,01 versus 0 .47 t 0.02 cm0. p = 0 .006).
Discriminate function analysis was performed to identify ear .
Percutaneous balloon aortic valvuluplasly has been demon-
strated to significantly enlarge aortic valve area in elderly
patients with aortic stenosis (II . Because of the improve-
ment in hemodynamics, great enthusiasm has been gener-
ated for aortic valvuicnplasty as a palliative procedure for
nonoperative patients (2). Although hemodynamic status is
improved, immediate results are inferior to those of aortic
valve replacement and long-term symptomatic relief is infe-
rior to that achieved with valve replacement (3) . For those
reasons, clinical investigation has focused on subgroups of
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tables that indepeodeatty predicted improved probability of set.
vhal. Eight variables were sigstifne8y and i odependeullp pre
.
dative . These Included age, initial cardiac output, initial tell
ventricular spstane pressures, initial left ventricular sod-6mtoic
pressures, presence of coronary airy disuse, New York Heart
Association dyspsea classification, naaher of balloon initiations
and final valve ores. Pmm this analysis, patient survival prat
hilities at I year varying between 50% and 20% could be
cslatatcd
. Althae 1t both initial and fund severity of aortic
stenosis were pagrwstkally important an anivoriale anal is,
discriminant hnnction o alysls revealed that only Road severity d
aorrit stenosis wss propostie .
Tour observations
sanest
that subgroups of patients with
lower a higher mortality rates can be Identified after balloon
aortic valveloplmty . The presence of left
ventricular
dysfwactlau,
the presence of eunwary artery disease and the use of mmflile
balloon infntions adversely nReet long-term propwis . Con-
versely, effective valvuloptasty provides modest impmwmem is
survival prohahilily,
(J Am Coft Cordial 1991;17:193-6)
patients With prohibitive operative risk . Even in this patient
population, insufficient data exist as lu the long-lens conse-
quences of balloon aortic valvuloplasty .
The Mansfield Scientific Aortic Valvuloplasty Registry
was organized to provide data to the Food and Drug Admin-
istration regarding aortic valvuloplasty . This Registry has
prospectively treated with balloon aortic valvuloplasty a
large population of elderly patients who are at high risk for
valve replacement. Because predefined entry criteria were
established . the Registry provides a unique opportunity to
analyze the impact of balloon aortic valvuloplasly on long-
term survival for a well defined patient subgroup. In this
report we present the overall survival data and an analysis of
determinants of improved survival rates after balloon aortic
valvuloplacly .
Methods
Patient selection. The Mansfield Registry began enrolling
patents from 27 medical centers in North America in De-
over-l own, nib so
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camber 1986 . Patient recruitment continued until November
1987, At [hat time the National Heart . Lung . and Blood
Institute-sponsored Balloon Valvuloplasty Registry was or-
ganized . Toassure that overlap of data did not occur, further
enrollment in the Mansfield Registry ceased at that point .
Between December 1986 and July 1987, a total of 538
patients underwent balloon aortic valvuloplasty at the par-
ticipating institutions
. Forty-six patients were treated for
clinical indications outside of the Registry protocol. The
current report is hated on the 492 patients whose clinical and
vital status was followed for m6 months .
To be eligible for enrollment, patients were required to
have severe aortic stenosis (valve area
.0
.7 cm` or mean
gradient re40 mm Hg) and to be at high risk for surgical valve
replacement . Clinical characterieties to connote increased
risk included advanced age (88% of patients), severe coro-
nary artery disease (23%), poor ventricularfunction (30%) or
co-morbid medical illnesses (70%). In addition, 31% of the
told] group had been formally denied surgical valve replace-
ment, as documented in writing by the consulting cardiovas-
cular surgeon. Patients were excluded if they were asymp-
tomaric, had infective endocarditis or had subvalvularaortic
stenosis
.
Operative procedure . Technical aspects of valvuloplasty
in the present series are presented elsewhere
(4) .
Briefly,
balloon aortic valvuloplasty was performed by the retro-
grade technique employing the femoral artery for vascular
access in 452 patients, by brachial approach in 30 patients
and by the transseptal, anterograde approach in 10 patients .
Hemodynamic data including right heart pressures, cardiac
output and simultaneous aorlie-left ventricular pressure
rate asurements were obtained from all patients before valvu-
loplasty
. Contrast angiography was performed in the 272
patients who had sufficient clinical stability to tolerate the
contrast dye load
. Calheterization of the left ventricle was
performed with standard angiographiecatheters according to
each investigators technique
. An exchange guide wire tech-
nique was used to advance the valvuloplasty balloon cathe-
teracross the aortic valve
.The number of balloon inflations,
duration of balloon inflations, use of dual balloon technique
and final balloon size employed were left to each investiga-
tor's discretion,
Data collection. Each clinical
site prospectively collected
data with use of a standard case report form
. Data were
collected by the principal investigator or a nurse investigator
at each institution and were reviewed for accuracy by each
principal investigator before submission to Mansfield Scien-
tific . Quality assurance of case report forms was performed
by two Mmtsield Scientific nurse monitors who regularly
visited each site and reviewed rrginal data including patient
charts and catheterization reports to verify the accuracy of
submitted data .
Statistical Analysis, Dichotomous variables were tested
by chi-square analysis and continuous variables by Student
1-tests . Actuarial life table analysis (5) was employed to
analyze the variation in survival . Multivariate analysis w,s
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Figure L Ufc-tablr analysis of predicted long-term survival (closed
darts) after hospital aorlie vatvuloptaty. Event-free survival
(cross a) is defined as survival without need for repeat valvuloplasty
ui valve replacement,
used to analyze the independence of univatiette predictors of
survival and to develop a model for survival probability .
Results
During the enrollment period from December 1986 to-July
1987, 492 patients underwent aortic valvuloplasty under the
Mansfield Registry protocol . There were 37 in-hospital
deaths (7.5%) and an additional four patients underwent
emergency aortic valve replacement before hospital dis-
charge. The details of procedural success (4), in-hospital
morbidity (6,7)
and complications (8) are presented else-
where.
Survival (Fig. 1)- For the purposes of this analysis,
follow-up was terminated at the time of death, aortic valve
replacement or repeat aortic valvuloplasty . Clinical condi-
tion or vital status was determined in 488 (99%) of the 492
patients
. These patients were followed up for e-6 months .
During the follow-up period (median 7 months, range 0 to
18 .8), 81 patients had repeat valvuloplasty or valve replace-
ment and 117 patients died . At t year, the survival rate was
64% and the event-free survival rate (absence of death,
repeat valvuloplasty or valve replacement) was % .
Fsoedonal status, Detailed reports per!ai„ ing to func-
tional stams were available in 304 of 334 patients surviving
e-6 months, Subjective lessening of symptoms had occurred
in 201 (66%) of the 304 patients. At entry into the Registry,
4% of patients were in New Yak Heart Association symp-
lum ^lass I, 14% in class il . 45% in class Ill and 37% in class
IV . At last follow-up, 26% were in class 1, 42% were in class
It . 26% in class Ill and 6%a in class IV .
Clinical predictors of survival (Table IA). To detect pre-
dictors of survival, hemudynamic and procedural variables
JACC Vat. 17, Nn I
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Table 1 . Dote minams of Long-Tens Survival After
Aortic Valvutoplasty
Congestive (adore
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45 NS
23
16 NS
were compared in the 334 patients (Group I) who survived
and the 117 patients (Group 2) who died during follow-up
.
Age. gender distribution and history of stroke were simdat
for both groups . Patients who died had more frequently had
a previous myocardial miarelien (p < 0 .005) . Almost half
(481)) of Group 2 patients had severe ventricular dysfunc-
tion, whereas significantly fewer (22%I of Group I patients
did so (p < 0!101) . Similarly
. Group 2 patients were more
symptomatic and
had a greater frequency of symptoms of
congestive failure, fatigue and eoerliunal dyspnea. In con-
trast, symptoms largely unrelated to ventricular function
(angina and syncope) were similar for both groups
.
alemadynamic factors {Table 1B) . Hemodynamic varia
bles documented the worsened cardiac function of Group 2
patients . These patients had higher pulmonary artery sys-
O'NEILL
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tolic pressure, higher mean pulmonary artery pressure and
lower left ventricular systolic and higher left vemricular
end-diastolic pressures . The initial cardiac output and aortic
valve gradient were lower and aortic valve Urea was signif-
icantly smaller in Group 2 patients . Coronary angiography,
performed in 405 of the 492 patients, revealed that Group 2
patients had more extensive coronary artery disease and a
lower incidence of normal arteriograms
.
Procedural factors (Table 1C) . Patients who died had,
initially
. a smaller valve area and lower cardiac output than
those that survived- The efficacy of the valvulaplasty may
have been correlated with improved survival hecaese final
aortic valve area and final cardiac output were higher its
Group 1 patients. Although final valve areas were different
between groups, no difference was present in final transaor
tic gradients.
l)nivariate and multivariate, predicmrs of survival- Anal-
ysis of univariate predictors suggested 16 variables that
might be correlated with prognosis in these patients . These
variables were subjected to discriminate function analysis
for the 391 discharged patients who had data recorded for all
16 variables. There were eight variables that independently
and significantly correlated with survival. In decreasing
order of significance, survival was greater in patients with
higher initial left ventricular systolic pressure, absence of
coronary artery disease, higher initial cardiac output, better
functional class, lower left ventricular end-diastolic pres-
sure, greater final valve area, younger age and fewer balloon
inflations performed
. The overall multivariate analysis
yielded a highly significant difference (p < 0 .001) between
"high risk" and "low risk" subgroups
. On the basis of this
analysis . 68% of patients could be correctly classified as
survivors or nonsurvivors. Discriminate analysis allowed
formulation of an equation to predict survival probability for
each patient
. This equation is written as follows: Discrimi-
nate score = 0 .612 + 0.020 (age in yearsl + 0.023 (left
ventricular end-diastolic pressure in mm Hg) + 0
.881 (coro-
nary angiography") + 3 .371 (initial Mew York Heart Asso-
ciation class) + 0 .014 (left ventricular syeloic pressure in
mm Hg) - 0 .782 (pestprocedure aortic valve area)
. On the
basis of this equation patient quintiles could be established
with survival probability values of 80%, 6650, 55%9, 42% and
25% (Fig. 2) .
Clinical variables that independently improved survival
probability included younger age (p < 0.0001), lower New
York Heart Association class (dyspnea level) (p < 0
.0001)
and absence of coronary artery disease (p < Q
.0001) . Unfor-
tunately' • a systematic analysis of
global or regional ventric-
ular function was not conducted in this patic^t cohort
.
Variables of ventricular function that were c 7tecred in-
cluded cardiac output and left ventricular systolic and end-
diastolic pressures
. Each of these variables was indepen-
dently predictive with improved prognosis . Patients with
I = coronary artery disease peosenL 0 = coronary artery dsease absent .
B . Hemodyoamies and AnenoOspSy
I9esonres Imni Hg) Im®n = Sin
lumanary artery syatohc 43 '- 1 54 ' 2 J 001
Mean pumrmary artery 28 o 1 36'_ 1 0 .005
LV systole 208"- 188 1 4 0001
LV end-diastolic Is-1 71'I Jul
Coronary arteriography 158 of
palkmal
Nnernal aned65 46 27
Mid CAD to
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-50% slenosis
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A . Clinical CharacMistia
gender t% of patients)
MA . 43 .1 50 .4 NS
Female 56.9 496
Asia IYO 7S .6 n7
782'0
.5 NS
Previous Ml I% of ptem)
0 .003
severe vemricuinr dysfunction 57259128[I 45153140<1 <0 .Wl
Press-, CVA (% f pntinelot 3 .9 51 NS
Symptoms 108 of pauenls)
C . Resin otValvatnplarr y
Cardiac output (Iheriein)
mint 41 = o
.27 3 .44 Or[ 0.001
Final 4 .24 0 0.07 3
.79 x 0.12 0.001
V
.Ive area (anc)
Initial 0 .52 ' 0.01 0.47 - 0 .02 4006
Final
0.85 x 0.02 0.78 x 0 .03 0,04
Transaonic gradient Imrs Hsi
Initial
62 .0 ± 12 54,0 *- 22 0 .001
Final 10.0 0 0.7 28 2 x 12 NS
1 96
	
a arl! .! .
SURVIVAI . AITER AORTIC VALVOLaeLASIY
Disoriminant Scores
Figure 2. Relation between discriminate score
and survival pmba-
bility . A discriminate score was calculated for all patients and
patients were subdivided into gaimiles. Risk of death was low
(--209)
for
patients with a discriminate score -0.80 or less and was
very high 180>1 for patients with a score w0 .96 .
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higher initial cardiac amput (p c 010 11, higher left ventric-
ular systolic pressure (p c 0 .0001) and lower left ventricular
end-diastolic pressure had a greater likelihood of survival
(p c 0.0001). Initial valve area and initial valve gradient did
not independently predict altered survival probability.
Severity of nestle stenosis. Although initial severity of
aortic stenosis nas not independently predictive, final sever-
ity of aortic stenosis significantly affected survival Greater
anrlic valve area independently predicted improved survival
(p < 0.0001} . Life table analysis based on
final valve area
was performed to determine the level of valve area that best
segregated patients who died or survived (Fig . 3) . One year
cumulative survival for patients with a final valve area of
>0.5 cm' was 44% compared with 63% for patients with a
valve area >0.5 cm'- (p = 0.02). When n5O .6 c r -2 was used as
a segregation point, survival was 51% versus 62% (p = 0 .06).
When 50.7 cm
2 was used as a segregation point, no differ-
ence in survival probability was noted (63% sersus 58%,
p = 0 .105) . Although a greater final aortic valve area
)ACC Vel . 17.N .. I
tam5ary
1991197_8
Figure 3. Comparison of the survival curves for patients with a posipmcedure
aortic valve area IAVAI<-0
.5cm= or>11.5cnv IAI.patientswithapostprocedure
valve area -0.6 cm 2 or >0.6 cm'-
IBI and patients with a postprocedure valve area
N .7
cm or >0.7 cm'- (CI .
IACC Vol 17. Ne . 1
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improved survival probability . attempts to optimize fina!
valve area by use of larger balloons and a greater number of
balloon inflations did not independently predict improved
survival probability. In fan . a higher number of inflations
predicted Ip a 0.0001) that survival was less likely . Finally .
in-hosphal complications did not affect long-term survival .
Discussion
The Mansfield Renlary experience . The Mansfield Scien-
tific Aortic Valvuloplast Registry has provided an opportu-
nity to assess the long-term prognosis of a large number of
elderly patients with severe, symptomatic aortic stenosis .
The Registry has collected the largest number of nonsurgical
patients with severe aortic stenosis reported to date . Ac-
cordingly, it has provided a unique opportunity to study
those variables interacting or associated with valvuloplasty
to affect survival . Careful analysis of this patient cohort may
provide insight as to whether or nut balloon aortic valvulu-
plasty hcacficially alters survival probability . With this in-
formation . Clinicians might better identify patients most
likely to benefit from valvuloplasty,
To determine the clinical utility of valvulopfasty, the
potential benefits must he weighed against the risk . In this
Seminar, McKay (4), Holmes et al . 16) and Inner (7) clearly
delineate the relatively high morbidity of this procedure in
the Mansfield Registry, Because the Registry enrolled pa-
tients early in the development of aortic valvuloplasty . this
morbidity rate was not surprising . Block (81 has shown that
morbidity and in-hospital mortality dramatically decrensed
in the second half of the Registry . This improvement in
safety was related both to increased operator experience and
to improvement in catheter and introducer sheath technol-
ogy . Review of the long-term prognosis reveals that in-
hospital complications did not affect long-term survival. Of
the procedural factors that were analyzed, methods of opti-
mizing final valve area including increasingly larger balloons
and double balloon technique also failed to improve progno-
sis. A greater number of balloon inflations was in fact
associated with worse prognosis . A greater number of infla-
tions may have been required when dilation was unsuccess-
ful. Second, a greater number of balloon inflations with the
attendant transient hypotensioa may have worsened ventric-
ular function after the procedure. Irrespective of these
postulates, these data suggest that caution is required for
balloon inflation protocols with respect to number and extent
of balloon inflations.
Long-lermsurvival after valvuluplesty . In analyoseg long-
term survival . it must be emphasized that a highly sympto-
matic, elderly patient population was treated . The patients
were at high risk for aortic valve replacement and were not
surgical candidates . 'fhe overall I year actuarial survival for
this patient cohort was
63ff .
Since a true control group is
unavailable, only comparison with previously published
natural history studies is possible . Ross and Braunwald 191
demonstrated
long ago the poor outcome of
patients with
O'NEILL
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aortic stenosis after symptom onset
; in their series the
average life expectancy was 3 years . More recently,
O' Keefe et al . (10) followed up an elderly medically treated
patient cehnn that closely approximates the Mansfield Reg-
istry patients
. Actuarial survival at I year was 50% for 5J
patients followed up from 1978 to 1985 ; average age was 77
years. In comparison, a l year survival rate of 78% was
reported by Safian et al . i t 1) and and month survival rate of
86% was reported by Letac et al
. r2)
. These reports and the
635, survival rate in the Mansfield Registry suggest that a
modest survival advantage may be achieved with aortic
valvuloplasty.
Prognosticsariables
. tini'variate analysis of differences on
subgroups of patients who were alive or died during fol-
low-up provides insight into prognostic variables . Previous
investigators 19,12) round that symptoms of heart failure
were associated with a much shorter survival time . Simi-
larly . symptoms of congestive heart below, fatigue and
exenlonal dyspnca were significantly more common in
pa-
rents
in the Mansfield Registry who died . Other ieivtarcal
variables that have prognostic value included a history of
previous myocardial
infarction and a history of severe
ventricular dysfunction
nfnfornmlio  obrnrnrd from cardiac cmheterimztion pro-
riled further rvognasfir darn. Uuivariate analysis demon-
strated that coronary atterv disease was more prevalent in
patients why died. In addition to assessment of systolic
ventricular function and status of the coronary arteries,
catheterization provided further useful prognostic data . Pa-
tients who died had high pulmonary artery, pulmonary
wedge and left ventricular end-diastolic pressures . Left
ventricular systolic pressure and cardiac output were signif-
icantly lower in patients who died, suggesting that these
patients were unable to generate adequate myocardial force,
Finally . patients who died had a smaller aortic valve area
before and after valvuloplasty- Rahimtaola (13) reviewed the
natural history of patients with aortic stenosis and demon-
strated that patients with severe aortic stenosis (valve area
< 0 .8 cm) have a worse prognosis than patients with a larger
valve area. Analysis of the Mansfield Registry data demon-
strates that further gradations of prognosis exist in the
patients with severe aortic stenosis . The valve area that
appears to best segregate survival probability in
Registry
patients appears to be 0 .5 cm', Cribier et al
. (14) suggested
that the final valve gradient be used as a criterion for
successful valvuloplasty . From a prognostic standpoint, our
data do not justify this. Final aortic
gradients
were nearly-
identical in patients who survived or died . Because the
gradient is contingent on transvalvular flow, transient alter-
ations of flaw might dramatically affect the gradient without
altering orifice area. These alterations in flow would most
likely affect patients with ventriculardysfunetion, artificially
lowering the gradient in this subgroup.
Predictnes of poor probability of survival after valvulo-
plasty . Because the Mansfield Registry was not a random-
ized study
. the most vexing question encountered was
19R
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whether aorhc valvuloplasty had any effect on prognosis .
Analysis of surviving and nonsurviving subgroups of pa•
bent, clearly demonstrates that sicker patients with worse
venuicular reaction and smaller valve area were more likely
to die. Multivnn:tc analysis was performed to identify
feelers independently associated with altered survival prob-
ability- This analysis was particularly important in determin-
ing whether baseline severity of aortic steal alone ac-
counted for the poorer survival probability in patients who
died. Although univanate analysts demonstrated that both
initial and final valve areas were higher in patients who
survived, on multivariate analysis only final valve area was
independently predictive of altered survival prohability .
Thus-effi,.acy of valvuloplasty was independently predictive
of improved survival . Patient survival was further analyzed
on the basis of final valve area achieved after valvutoplasty
.
Survival curves were calculated with different breakpoints
for the final valve area achieved after valvuloplasty . The
greatest benefit seems to have been achieved at a valve area
of 0.5 or 0.6 cm'- . This finding suggests that . i n fact . the
greatest prognostic benefit was achieved in patients with the
most severe aortic stenosis . Subgroup analysis suggests that
successful valvuloplasty indeed did impart a survival advan •
lage .
Symptomatic improvement after valvuloplasty . At follow-
up . 669e of patients in the Mansfield Registry had a lessening
of SVmp(Oms and 26e1 Were asymptumatic . Disappointingly .
the majority of patients did not have lasting benefit from this
procedure and the symptom free survival rate was only 41% .
In comparison with yalvuloplasty, aortic valve replacement
has allowed excellent long-term palliation of symptoms .
Levinson et al . 1151 followed up 52 octogenarian patients
after aortic valve replacement and found that 90% of surviv-
ing patients were asymptumatic or had mild symptoms .
Holland et al, (31 previously demonstrated that vatvsloplasty
resulted in less symptomatic relief than did aortic valve
replacement
. In view of these findings, aortic valve replace •
merit must still be considered the preferred mode Of therapy
for elderly patients who are surgical candidates .
The Registry follow-up suggests brat palliation of symp-
toms does occur after aortic valvuloplasty . Ilnfortunalcly,
as Bashore el al, (16) demonstrated in this Seminar
. a poor
correlation exists between functional class at follow-up and
level of improvement in aortic valve area . Furthermore,
restenosis cannot be predicted on the basis of symptom
status. Nevertheless . aortic valvuloplasty does provide
short-term palliation of symptoms with two-thirds of surviv-
ing patients having subjective symptomatic relief
. Because
no other therapeutic modalities were available for these
patients. even this short-term palliation has clinical merit .
Conclusions . The Mansfield Registry has provided insight
into the clinical course of a large group of elderly symplo-
maic patients with severe aortic stenosis who were treated
with balloon valvutoplasty early in the development of the
procedure
. Follow-up of the patients suggests that modest
clinical benefit was achieved by valvuloplasty . Palliation of
net Cal . 17, No l
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symplunis occurred in two-thirdveipatients who survived to
6-month follow-up. Improvement as defined by increase in
valve area achieved did impart a survival advantage, cspe-
ridly in patients with extremely severe aortic stenosls •
Future directions for clinical research are apparent . Pro-
cedural and catheter modifications must Occur to lessen
in-hospital morbidity . More elfeetive methods of nonopera-
live improvement in valve orifice area must be sought .
Methods to limit reslenosi5 must he
developed-
In the
interim, guarded optimism for the use of aortic valvuloplasty
in elderly, noneoperalive patients with aortic stenosis is
warranted .
We thank Sander A. Klomki for easen wcretaricl esi,,unea in the prepare-
ion
of this manuwript .
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